Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group
H. R. Ashbee(Leeds General Infirmary), Kathrin Tintelnot(Robert Koch Institute), P. Vachkov(Bursa Uludağ Üni̇versi̇tesi̇), A Tomsíková(University Hospital St. Ivan Rilski), B. Dupont(Délégation Paris 5), I. Surmont(Czech Academy of Sciences, Institute of Microbiology), Erja Chryssanthou(Karolinska University Hospital), J. Zala(Robert Koch Institute), M.A. Viviani(Hôpital Necker-Enfants Malades), Beyza Ener(Bursa Uludağ Üni̇versi̇tesi̇)
Cited by 134
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436